When
Thursday, July 16, 2026
to
Saturday, July 18, 2026
Where
Terranea Resort
100 Terranea Way
Rancho Palos Verdes, CA 90275
Planner
Objectives
- Share insights on practice patterns in the treatment of hematologic malignancies, including AML, CLL, MDS, MF, MM, and NHL
- Discuss the current therapeutic landscape for patients with hematologic malignancies, including AML, CLL, MDS, MF, MM, and NHL
- Explore how best to select and sequence treatment for patients with hematologic malignancies, including AML, CLL, MDS, MF, MM, and NHL
Attendee Testimonials
What your peers said about their experience at the 2025 Hematologic Malignancies National Summit.
“Great discussions focused on real‑world practice. I enjoyed networking with colleagues from across the country, and the Summit was extremely well organized with excellent communication by the staff.”
"Excellent location. Worth the travel away from home."
“People felt comfortable speaking up and sharing opinions—something you don’t often experience at large conferences.”
“The presentations were excellently presented with great discussion panels, and the moderators were engaging and fun to listen to. It was thought‑provoking and truly practice changing for me.”